Comparison of tumor mutational burden (TMB) in PBRM1/BAP1-based subsets of advanced renal cell carcinoma (aRCC).

被引：1
|
作者：
Pal, Sumanta K.
Madison, Russell
Chung, Jon
Agarwal, Neeraj
Bergerot, Paulo Gustavo
Bosse, Dominick
Sokol, Ethan
Hartmaier, Ryan James
Miller, Vincent A.
Ross, Jeffrey S.
Choueiri, Toni K.
Ali, Siraj Mahamed
机构：
[1] City Hope Comprehens Canc Ctr, Duarte, CA USA
[2] Fdn Med Inc, Cambridge, MA USA
[3] Huntsman Canc Hosp, Salt Lake City, UT USA
[4] Fed Univ Sao Paulo UNIFESP, Sao Paulo, Brazil
[5] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[6] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.634
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
634
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma
    Chowdhury, Basudev
    Porter, Elizabeth G.
    Stewart, Jane C.
    Ferreira, Christina R.
    Schipma, Matthew J.
    Dykhuizen, Emily C.
    [J]. PLOS ONE, 2016, 11 (04):
  • [32] The impact of PBRM1 and BAP1 expression on outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with VEGF-targeted therapy (TT).
    Fay, Andre Poisl
    de Velasco, Guillermo
    Gray, Kathryn P.
    Ho, Thai Huu
    Song, Jiaxi
    Kapur, Payal
    Albiges, Laurence
    McDermott, David F.
    Heng, Daniel Yick Chin
    Brugarolas, James
    Choueiri, Toni K.
    Signoretti, Sabina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [33] PBRM1 Mutations as a Predictive Biomarker for Immunotherapy in Metastatic Renal Cell Carcinoma: A Systematic Review
    Castello Dias Carneiro, Andre Paterno
    Marques Monteiro, Fernando Sabino
    Soares, Andrey
    [J]. KIDNEY CANCER, 2021, 5 (02) : 79 - 92
  • [34] PBRM1 alteration in clear cell renal cell carcinoma increases tumorigenicity through ALDH1A1 upregulation
    Schoenfeld, David
    Su, William
    Zairis, Sakellarios
    Mathur, Deepti
    Rabadan, Raul
    Parsons, Ramon
    [J]. CANCER RESEARCH, 2016, 76
  • [35] PBRM1 and KDM5C loss modulate the tumor immune microenvironment of clear cell renal carcinoma
    Valdivia, Carlos
    de Nicolas-Hernandez, Javier
    Lanillos, Javier
    Martinez-Montes, Angel M.
    Arenas, Alicia
    Mellid, Sara
    Monteagudo, Maria
    Torres, Raul
    Jose Caleiras-Pires, Eduardo
    Leandro, Javier
    Robledo, Mercedes
    Rodriguez-Antona, Cristina
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 68 - 69
  • [36] Immune microenvironment in clear cell type renal cell carcinoma with loss of PBRM1 protein expression
    Miura, Yuji
    Motoshima, Takanobu
    Inoshita, Naoko
    Okaneya, Toshikazu
    Takano, Toshimi
    Komohara, Yoshihiro
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [37] Prognostic role of PBRM1 marker expression in clear-cell renal-cell carcinoma
    Zaridze, D. G.
    Mazurenko, N. N.
    Bezhanova, S. D.
    Maksimovich, D. M.
    Shangina, O., V
    Draudin-Krylenko, V. A.
    Mukeria, A. F.
    Matveev, V. B.
    [J]. ONKOUROLOGIYA, 2019, 15 (01): : 23 - 31
  • [38] Significance of PBRM1 mutation in disease progress and drug selection in clear cell renal cell carcinoma
    He, Donghua
    Ma, Tianyan
    Yi, Ni
    Zhang, Sijie
    Ding, Guanxiong
    [J]. BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2023, 40 (04) : 3901 - 3915
  • [39] Expression of the tumor suppressor PBRM1 in relation to clinicopathological features of clear cell renal cell carcinomas
    Hoegner, Anica
    Krause, Hans
    Jandrig, Burkhard
    Fuller, Tom Florian
    Patzak, Andreas
    Kilic, Ergin
    [J]. BJU INTERNATIONAL, 2015, 116 : 12 - 12
  • [40] VHL, PBRM1, and BAP1 mutation variants and response to first-line therapies in patients with metastatic clear-cell renal cell carcinoma (mRCC)
    Zhu, Jessica
    Hu, Junxiao
    Lam, Elaine T.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
12345